Farmaceutisch concern · Duitsland
Bayer
Een concern van 69 bedrijven met 1.812 geneesmiddelen in 13 landen.
Concernstructuur
69 bedrijven in 25 landen
Laden…
Farmaceutisch concern · Duitsland
Een concern van 69 bedrijven met 1.812 geneesmiddelen in 13 landen.
69 bedrijven in 25 landen
Eén gratis account voor de Prognia-apps: Ward om te studeren, Osler voor klinische antwoorden met hun bronnen, en het netwerk om je collega’s te vinden.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Alle geneesmiddelen van alle bedrijven in het concern, actuele eerst.
1–25 van 1.812
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| 8-HOUR BAYER650mg · Tablet, extended release | Acetylsalicylic acid | Verenigde Staten | Niet in de handel | 1965 |
| ACTIRA 400 MG/ 250 ML SOLUCION PARA PERFUSION0,436 g · Solución para perfusión | Moxifloxacin | Spanje | In de handel | 2018 |
| ACTROMADOL 660 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA660 mg · Comprimido de liberación modificada | Naproxen | Spanje | In de handel | 2018 |
| ACTRON12.5mg · Tablet | Ketoprofen | Verenigde Staten | Niet in de handel | 1995 |
| ACTRON COMPUESTO 267 MG/133 MG/40 MG COMPRIMIDOS EFERVESCENTES133 mg + 40 mg + 267 mg · Comprimido efervescente | Paracetamol, Caffeine, Acetylsalicylic acid | Spanje | In de handel | 1968 |
| ACTRON COMPUESTO 267 MG/133 MG/40 MG COMPRIMIDOS EFERVESCENTES133 mg + 40 mg + 267 mg · Comprimido efervescente | Paracetamol, Caffeine, Acetylsalicylic acid | Spanje | In de handel | 2018 |
| ACTRON COMPUESTO 267 MG/133 MG/40 MG COMPRIMIDOS EFERVESCENTES133 mg + 40 mg + 267 mg · Comprimido efervescente | Paracetamol, Caffeine, Acetylsalicylic acid | Spanje | In de handel | 2016 |
| ADALAT10mg | 20mg · Capsule | Nifedipine | Verenigde Staten | Niet in de handel | 1985 |
| ADALAT LA 30 TABLET 30 mg30 mg · Tablet, film coated | Nifedipine | Singapore | Toegelaten | 1994 |
| ADALAT OROS 30 mg, COMPRIMIDOS DE LIBERACION PROLONGADA30 mg · Comprimido de liberación prolongada | Nifedipine | Spanje | In de handel | 1992 |
| ADALAT XL30 mg · Tablet (Extended-Release) | Nifedipine | Canada | In de handel | 1992 |
| Adempas | Riociguat | EU (EMA) | Toegelaten | 2014 |
| ADEMPAS2.5 mg · Tablet | Riociguat | Canada | In de handel | 2013 |
| ADEMPAS2 mg · Tablet | Riociguat | Canada | In de handel | 2013 |
| ADEMPAS1 mg · Tablet | Riociguat | Canada | In de handel | 2013 |
| ADEMPAS0.5mg | 1.5mg | 1mg | 2.5mg | 2mg · Tablet | Riociguat | Verenigde Staten | In de handel | 2013 |
| ADEMPAS1.5 mg · Tablet | Riociguat | Canada | In de handel | 2013 |
| ADEMPAS0.5 mg · Tablet | Riociguat | Canada | In de handel | 2013 |
| Adempas 0,15 mg/ml, granulaat voor orale suspensieGranulaat voor orale suspensie | Riociguat | Nederland | Toegelaten | 2014 |
| ADEMPAS 0,5 mg comprimidos recubiertos con pelicula0,5 mg · Comprimido recubierto con película | Riociguat | Spanje | Toegelaten | 2014 |
| Adempas 0,5 mg, filmomhulde tablettenFilmomhulde tablet | Riociguat | Nederland | Toegelaten | 2014 |
| ADEMPAS 1,5 mg comprimidos recubiertos con pelicula1,5 mg · Comprimido recubierto con película | Riociguat | Spanje | In de handel | 2014 |
| ADEMPAS 1,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA1,5 mg · Comprimido recubierto con película | Riociguat | Spanje | In de handel | 2023 |
| Adempas 1,5 mg, filmomhulde tablettenFilmomhulde tablet | Riociguat | Nederland | Toegelaten | 2014 |
| ADEMPAS 1 mg comprimidos recubiertos con pelicula1 mg · Comprimido recubierto con película | Riociguat | Spanje | In de handel | 2014 |
Waar het geneesmiddelen registreert of maakt, en hoeveel daarvan actueel zijn.
| Land | Geneesmiddelen | Actueel | Vroeger | Bedrijven |
|---|---|---|---|---|
| Canada | 387 | 128 | 259 | BedrijvenAlle geneesmiddelen |
| Spanje | 300 | 224 | 76 | BedrijvenAlle geneesmiddelen |
| Taiwan | 190 | 58 | 132 | BedrijvenAlle geneesmiddelen |
| Brazilië | 186 | 48 | 138 | BedrijvenAlle geneesmiddelen |
| Nederland | 155 | 155 | 0 | BedrijvenAlle geneesmiddelen |
| Verenigde Staten | 147 | 141 | 6 | BedrijvenAlle geneesmiddelen |
| Saoedi-Arabië | 118 | 118 | 0 | BedrijvenAlle geneesmiddelen |
| Servië | 112 | 112 | 0 | BedrijvenAlle geneesmiddelen |
| Roemenië | 88 | 0 | 88 | BedrijvenAlle geneesmiddelen |
| Singapore | 58 | 58 | 0 | BedrijvenAlle geneesmiddelen |
| Kroatië | 41 | 41 | 0 | BedrijvenAlle geneesmiddelen |
| Europese Unie (EMA) | 28 | 21 | 7 | BedrijvenAlle geneesmiddelen |
| Colombia | 2 | 0 | 2 | BedrijvenAlle geneesmiddelen |
Ook geregistreerd in: Australië, Frankrijk, Italië, Maleisië, Verenigd Koninkrijk, Zweden
De ATC-groepen waartoe de meeste van zijn geneesmiddelen behoren, grootste eerst.
De werkzame stoffen in de meeste van zijn geneesmiddelen.
Hoe de registers de naam schrijven, genormaliseerd: zonder rechtsvorm, accenten en hoofdletters.
Samengesteld door Prognia uit de openbare geneesmiddelen- en bedrijfsregisters hieronder. Logo’s worden niet gebruikt.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Source: European Medicines Agency (EPAR data).
Licentie: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licentie: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licentie: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licentie: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licentie: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licentie: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licentie: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licentie: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licentie: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Finnish Patent and Registration Office (PRH), Business Information System (YTJ), source query URL, record lastModified (no timezone supplied), retrieval date; CC BY 4.0. Structured extraction/selection by Prognia.
Licentie: Creative Commons Attribution (CC BY)
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licentie: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Licentie: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licentie: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licentie: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licentie: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licentie: Creative Commons Attribution
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licentie: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Brønnøysundregistrene / Regnskapsregisteret, latest filed company accounts, original organization number, fiscal period and retrieval date
Licentie: NLOD
Contains data under NLOD made available by Brønnøysundregistrene; cite source URL and retrieval date
Licentie: NLOD
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licentie: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licentie: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licentie: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licentie: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licentie: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licentie: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licentie: CC0
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licentie: Taiwan Government Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licentie: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Meld een fout of vraag verwijdering aanCorrecties van het bedrijf zelf zijn welkom.
Houd de geneesmiddelen van Bayer op Prognia juist, zie hoe zorgprofessionals ze gebruiken en beantwoord wat ze vragen. Een gesprek van 20 minuten, in het Engels.
Plan een gesprekBekende farmaceutische concerns, elk met al zijn bedrijven.
Gerangschikt naar hun aantal geneesmiddelen.